Surgery (Austin & Northern Health) - Research Publications

Permanent URI for this collection

http://hdl.handle.net/11343/187

Filters

2021 2
2
Reset filters

Settings
Statistics
Citations
Author: Angus, Peter × Author: Gow, Paul × End date: 2022 × Start date: 2021 ×

Search Results

Now showing 1 - 2 of 2
  • Item
    Thumbnail Image
    Epidemiology and Prognostic Significance of Rapid Response System Activation in Patients Undergoing Liver Transplantation
    Robertson, M ; Lim, AKH ; Bloom, A ; Chung, W ; Tsoi, A ; Cannan, E ; Johnstone, B ; Huynh, A ; O'Halloran, T ; Gow, P ; Angus, P ; Jones, D (MDPI, 2021-12)
    Patients undergoing liver transplantation have a high risk of perioperative clinical deterioration. The Rapid Response System is an intensive care unit-based approach for the early recognition and management of hospitalized patients identified as high-risk for clinical deterioration by a medical emergency team (MET). The etiology and prognostic significance of clinical deterioration events is poorly understood in liver transplant patients. We conducted a cohort study of 381 consecutive adult liver transplant recipients from a prospectively collected transplant database (2011-2017). Medical records identified patients who received MET activation pre- and post-transplantation. MET activation was recorded in 131 (34%) patients, with 266 MET activations in total. The commonest triggers for MET activation were tachypnea and hypotension pre-transplantation, and tachycardia post-transplantation. In multivariable analysis, female sex, increasing Model for End-Stage Liver Disease score and hepatorenal syndrome were independently associated with MET activation. The unplanned intensive care unit admission rate following MET activation was 24.1%. Inpatient mortality was 4.2% and did not differ by MET activation status; however, patients requiring MET activation had significantly longer intensive care unit and hospital length of stay and were more likely to require inpatient rehabilitation. In conclusion, liver transplant patients with perioperative complications requiring MET activation represent a high-risk group with increased morbidity and length of stay.
  • Item
    Thumbnail Image
    Clinical outcomes of patients with two small hepatocellular carcinomas
    Anh, DP ; Vaz, K ; Ardalan, ZS ; Sinclair, M ; Apostolov, R ; Gardner, S ; Majeed, A ; Mishra, G ; Kam, NM ; Patwala, K ; Kutaiba, N ; Arachchi, N ; Bell, S ; Dev, AT ; Lubel, JS ; Nicoll, AJ ; Sood, S ; Kemp, W ; Roberts, SK ; Fink, M ; Testro, AG ; Angus, PW ; Gow, PJ (BAISHIDENG PUBLISHING GROUP INC, 2021-10-27)
    BACKGROUND: Management of single small hepatocellular carcinoma (HCC) is straightforward with curative outcomes achieved by locoregional therapy or resection. Liver transplantation is often considered for multiple small or single large HCC. Management of two small HCC whether presenting synchronously or sequentially is less clear. AIM: To define the outcomes of patients presenting with two small HCC. METHODS: Retrospective review of HCC databases from multiple institutions of patients with either two synchronous or sequential HCC ≤ 3 cm between January 2000 and March 2018. Primary outcomes were overall survival (OS) and transplant-free survival (TFS). RESULTS: 104 patients were identified (male n = 89). Median age was 63 years (interquartile range 58-67.75) and the most common aetiology of liver disease was hepatitis C (40.4%). 59 (56.7%) had synchronous HCC and 45 (43.3%) had sequential. 36 patients died (34.6%) and 25 were transplanted (24.0%). 1, 3 and 5-year OS was 93.0%, 66.1% and 62.3% and 5-year post-transplant survival was 95.8%. 1, 3 and 5-year TFS was 82.1%, 45.85% and 37.8%. When synchronous and sequential groups were compared, OS (1,3 and 5 year synchronous 91.3%, 63.8%, 61.1%, sequential 95.3%, 69.5%, 64.6%, P = 0.41) was similar but TFS was higher in the sequential group (1,3 and 5 year synchronous 68.5%, 37.3% and 29.7%, sequential 93.2%, 56.6%, 48.5%, P = 0.02) though this difference did not remain during multivariate analysis. CONCLUSION: TFS in patients presenting with two HCC ≤ 3 cm is poor regardless of the timing of the second tumor. All patients presenting with two small HCC should be considered for transplantation.